Author

B. W.-L. Ng

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Y. Zhang· 2 shared A. Balia· 1 shared A. S.-L. Cheng· 1 shared B. Ma· 1 shared B. Nasiri Ahmadabadi· 1 shared C. Castillo· 1 shared E. C. McCulla· 1 shared H. N. Bell· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Y. Zhang

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer

S. L. DeAngelo, L. Zhao, S. Dziechciarz, M. Shin, S. Solanki, A. Balia, M. O. El-Derany, C. Castillo, Y. Qin, N. K. Das, H. N. Bell, J. A. Paulo, Y. Zhang, N. J. Rossiter, E. C. McCulla, , Y. M. Shah

This study recharacterizes RSL3 as a broad selenoprotein inhibitor, showing its potential as a therapeutic target for colorectal cancer by inducing ferroptosis.

bioRxiv · Mar 29, 2024 · PreprintCancer Biology

Diversification of Nucleoside Analogues as Potent Antiviral Drug Leads

S. Scheeff, Y. Wang, M.-Y. Lyu, B. Nasiri Ahmadabadi, S. C. K. Hau, T. K. C. Hui, Y. Zhang, Z. Zuo, R. W. Y. Chan, B. W.-L. Ng

The paper develops a diversified library of nucleoside analogues with enhanced antiviral efficacy and low cytotoxicity, featuring a novel carbobicyclic core structure.

bioRxiv · Jun 17, 2023Microbiology

Targeted Protein O-GlcNAcylation Using Bifunctional Small Molecules

B. Ma, K. S. Khan, T. Xu, J. X. Amada, Z. Guo, Y. Yan, A. S.-L. Cheng, B. W.-L. Ng

This paper develops OGTACs, bifunctional small molecules that enable protein-specific O-GlcNAcylation in cells, with applications for studying and targeting this modification in disease.

bioRxiv · Jun 9, 2023Cell Biology